Alphabiome raised $8M in Seed funding led by AIX Ventures to expand operations and enhance R&D efforts.
Alphabiome raised $8M in Seed funding led by AIX Ventures to expand operations and enhance R&D efforts.
05/06/25, 1:45 PM
Location
tel avivMoney raised
$8 million
Industry
genetics
machine learning
artificial intelligence
biotechnology
Round Type
seed
Investors
Aix Ventures
Alphabiome, a Tel Aviv-based company, raised $8M in Seed funding to advance technology that extracts genetic biomarkers from microbial DNA. The funding round was led by AIX Ventures and aims to expand operations and R&D. Alphabiome uses a proprietary AI model to decode the human microbiome. They recently conducted a trial identifying over 10,000 complex microbe-derived biomarkers related to drug efficacy.
Company Info
Location
tel aviv, tel aviv district, israel
Additional Info
Alphabiome is a Tel Aviv-based company focused on advancing technology that extracts genetic biomarkers from microbial DNA. It utilizes a proprietary AI model to decode the human microbiome, analyzing vast amounts of genetic data to identify valuable biomarkers for precision medicine. The company combines advanced AI with microbiome analytics, employing innovative mathematical models to uncover previously uncharacterized microbial DNA patterns.